DSDominique S. Scheepens

Dominique S. Scheepens

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dominique S. Scheepens has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Jeroen A. van Waarde

    Rijnstate Hospital, Department of Psychiatry, Arnhem, the Netherlands

    3 shared publications
  • Aart H. Schene

    Radboud University Nijmegen Medical Center, Department of Psychiatry, Nijmegen, the Netherlands; Department of Cognitive Neuroscience, Donders Institute for Brain Cognition and Behaviour, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands

    2 shared publications
  • Damiaan A. J. P. Denys

    Department of Psychiatry, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

    2 shared publications
  • Freek Ten Doesschate

    Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam Neuroscience, Amsterdam, the Netherlands; Rijnstate Hospital, Department of Psychiatry, Arnhem, the Netherlands

    2 shared publications
  • Guido Alexander van Wingen

    Amsterdam UMC

    2 shared publications
  • Henricus G. Ruhé

    Radboud University Nijmegen Medical Center, Department of Psychiatry, Nijmegen, the Netherlands; Department of Cognitive Neuroscience, Donders Institute for Brain Cognition and Behaviour, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands

    2 shared publications

Latest Publications

  • Open Access

    A Multicenter Retrospective Chart Review on the Effectiveness and Tolerability of Electroconvulsive Therapy in Adolescents and Young Adults With Major Depressive Disorder or Bipolar Depression

    by Nout Schukking, Karel W.F. Scheepstra, Isidoor O. Bergfeld, Jeroen A. van Waarde, Indira Tendolkar, Harm-Pieter Spaans, Annette J. M. Hegeman, Dominique S. Scheepens, Anja Lok

    Background: Major depressive disorder and bipolar depression in adolescents and young adults are prevalent and major contributors to the global burden of disease, whereas effective interventions are limited. Available evidence is insufficient to assess effectiveness and tolerability of electroconvulsive therapy in depressed adolescents and young adults. Methods: A retrospective chart review was conducted in patients with major depressive disorder or bipolar depression who underwent electroconvulsive therapy from 2001 to 2021 in 12 centers in the Netherlands. Patients were classified as young (15–25 years) and older adults (26–80 years). Primary outcome was effectiveness, expressed as response (≥50% reduction in rating scale score compared with baseline) and remission. Rating scale scores were cross-sectionally assessed at baseline and at the end of the index course. Outcomes of remitters were included in responders. Secondary outcome was occurrence of subjective cognitive impairment and adverse events. Long-term outcomes were not available. Results: In the young (n = 57) and older adult (n = 41) group, 40.4% and 56.1% (P = 0.153) of patients achieved response and 28.1% and 39.0% (P = 0.281) remission, respectively. Subjective cognitive impairment (80.5% vs 56.3%; P = 0.001) and transient cardiac arrhythmia (14.6% vs 2.8%; P = 0.020) were reported significantly more frequently in the older adult group. Conclusions: Despite significantly more comorbidity of personality disorders, autism spectrum disorders, and anxiety disorders, effectiveness in the young was similar to the older adults. Tolerability was even superior in the young, despite significantly more bilateral treatment. Electroconvulsive therapy could be considered a viable treatment option in depressed adolescents and young adults.


  • Open Access

    Negative cognitive schema modification as mediator of symptom improvement after electroconvulsive therapy in major depressive disorder

    by Dominique S. Scheepens, Jeroen A. van Waarde, Freek Ten Doesschate, Mirjam Westra, Marijn C.W. Kroes, Aart H. Schene, Robert A. Schoevers, Damiaan Denys, Henricus G. Ruhé, Guido A. van Wingen


  • Effectiveness of Emotional Memory Reactivation vs Control Memory Reactivation Before Electroconvulsive Therapy in Adult Patients With Depressive Disorder

    by Dominique S. Scheepens, Jeroen A. van Waarde, Freek Ten Doesschate, Mirjam Westra, Marijn C. W. Kroes, Aart H. Schene, Claudi L. H. Bockting, Robert A. Schoevers, Damiaan A. J. P. Denys, Henricus G. Ruhé, et al.

    Major depressive disorder (MDD) is a common mental disorder associated with substantial reductions in daily functioning. Initial treatment for MDD consists of psychotherapy and/or pharmacotherapy. A 2010 study1 reported that, even after receiving 4 different pharmacotherapeutic interventions, more than half of patients with depression do not recover. Electroconvulsive therapy (ECT) has been reported to be beneficial in patients with MDD resistant to pharmacologic treatment,2 although half of the patients undergoing ECT will not achieve full remission.3 Moreover, relapse rates after successful ECT are high, as one-third of patients can be expected to relapse within 6 months.4 More effective targeting of specific underlying psychopathological mechanisms of MDD may help improve ECT effectiveness, be associated with more rapid ECT response times, and decrease relapse rates after successful ECT.


  • Open Access

    The Link Between Structural and Functional Brain Abnormalities in Depression: A Systematic Review of Multimodal Neuroimaging Studies

    by Dominique S. Scheepens, Jeroen A. van Waarde, Anja Lok, Glenn de Vries, Damiaan A. J. P. Denys, Guido A. van Wingen

    Background: Adequate and timely identification of depression is essential to improve patient care. A potential method to achieve this is by using neuroimaging. Many neuroimaging studies have revealed widespread abnormalities in brain structure and function in patients with depression, but in most studies only single neuroimaging modalities were used. Links between abnormalities in brain structure and function need to be therefore further explored in order to define diagnostic and therapeutic applications. Methods: A systematic literature review according to preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines was conducted. Results: Out of 2,516 articles, only 14 studies were eligible to be included. These studies combined structural and functional neuroimaging methods in depressed patients compared to controls. Four studies reported a negative relationship between brain structure and function within the default mode network: reduced gray or white matter integrity in depressed patients compared to healthy controls was associated with enhanced neural activity or connectivity. The other studies reported positive relationships (two studies), mixed relationships (two studies), or no link (six studies) between structural and functional brain abnormalities. Conclusion: This systematic literature review revealed no robust relationship between abnormalities in brain structure and function in patients with depression. Remarkably, only 14 studies could be included and four of these suggested enhanced default mode network connectivity associated with reduced structural brain integrity. In the ongoing development of the diagnostic and treatment applications of neuroimaging, large-scale studies that combine structural with functional neuroimaging are required to determine the relationship between structural and functional abnormalities in depression.